Gujilde, Celso M.
HRN: 21-41-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/13/2022
06/15/2022
TOPICA
Ample Amount
Bid
Decubitus Ulcer (sacral Area)
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes